Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
PV-10 for Locally Advanced Cutaneous Melanoma	PV-10 (rose bengal sodium)	Melanoma	Skin Cancer	2018	View \| Download
Polatuzumab vedotin in combination with rituximab and bendamustine for the treatment of diffuse large B-cell lymphoma	Bendamustine (Treanda; EP-3102; Levact; Ribomustin; bendamustine hydrochloride monohydrate; bendamustine hydrochloride) , Polatuzumab vedotin (DCDS4501A; RG7596; RG-7596; Polivy) , Rituximab (MabThera; Rituxan; RG 105)	Diffuse large B-cell lymphoma (DLBCL)	Haematological Cancer and Lymphomas	2018	View \| Download
PLX-PAD for Critical Limb Ischaemia (with minor tissue loss) in Patients Unsuitable for Revascularisation	PLX-PAD	Critical limb ischaemia (CLI)	Cardiovascular System	2018	View \| Download
Perampanel (Fycompa) for Paediatric Epilepsy	Perampanel (Fycompa; E 2007; ER-155055-90)	Epilepsy	Neurology	2018	View \| Download
Pentetrazol for Idiopathic Hypersomnia and Narcolepsy Type 2	Pentetrazol (BTD-001)	Hypersomnia , Narcolepsy	Neurology	2018	View \| Download
Pembrolizumab in Combination with Epacadostat for Unresectable or Metastatic Melanoma	Epacadostat (INCB024360) , Pembrolizumab (Keytruda; MK-3475)	Melanoma	Skin Cancer	2018	View \| Download
Pembrolizumab in combination with Axitinib for Metastatic Renal Cell Carcinoma – first line	Axitinib (Inlyta; AG-013736) , Pembrolizumab (Keytruda; MK-3475)	Renal cell carcinoma (RCC)	Renal Cancer	2018	View \| Download
Pembrolizumab in addition to standard of care chemotherapy for extensive stage small cell lung cancer – first line	Pembrolizumab (Keytruda; MK-3475)	Small-cell lung cancer (SCLC)	Lung and Respiratory Cancer	2018	View \| Download
Pembrolizumab in addition to chemotherapy for locally recurrent, inoperable or metastatic triple-negative breast cancer - first line	Pembrolizumab (Keytruda; MK-3475)	Breast cancer	Breast Cancer	2018	View \| Download
Pembrolizumab in addition to Chemotherapy for Locally Advanced, Non-Metastatic Triple Negative Breast Cancer – neoadjuvant, first line	Pembrolizumab (Keytruda; MK-3475)	Breast cancer	Breast Cancer	2018	View \| Download